Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie
About Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Heidelberg Medical Center
2
Clinical Trials at Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie
During the past decade, Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
2015-06-01
2021-06-24
Completed
564
Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)
2018-10-18
2025-12-01
Active, not recruiting
662
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie
According to Clinical.Site data, the most researched conditions in "Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie" are
"Multiple Myeloma" (2 trials). Many other conditions were trialed in "Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie
Most popular intervention types in "Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (2 trials), "Dexamethasone" (2 trials), "Lenalidomide" (2 trials), "Isatuximab" (1 trials) and "elotuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie
The vast majority of trials in "Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie" are
2 trials for "All" genders.
Clinical Trials Status at Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie
Currently, there are NaN active trials in "Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".